Cargando…
Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719439/ https://www.ncbi.nlm.nih.gov/pubmed/33299311 http://dx.doi.org/10.2147/IJN.S293705 |
Ejemplares similares
-
Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene
por: Luo, Li, et al.
Publicado: (2016) -
Corrigendum to “Cell therapies in ovarian cancer”
Publicado: (2021) -
Corrigendum to: EGFR mediates LPA‐induced proteolytic enzyme expression and ovarian cancer invasion: Inhibition by resveratrol
Publicado: (2019) -
Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
por: Dianzani, Chiara, et al.
Publicado: (2021) -
Corrigendum to: Heterogeneity of germline variants in high risk breast and ovarian cancer susceptibility genes in India
por: Sharma-Oates, Archana, et al.
Publicado: (2018)